TrialBritish journal of cancer2024

Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial.

Yue-Yun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.